Video
FDA Receives New BLA for Dato-DXd in Pretreated EGFR+ Advanced NSCLC
Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD
The OncFive: Top Oncology Articles for the Week of 11/3
How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD
THIO Plus Cemiplimab Displays Efficacy in Checkpoint Inhibitor–Resistant NSCLC
Frontline Vibostolimab/Pembrolizumab Plus Chemo Meets Futility Threshold in ES-SCLC
Piecing Together the Proper BTK Usage in CLL
Real-World Experience With CAR T Varies From Trials in DLBCL
TAB-Follicular Lymphoma
Dr Moreno on the Pharmacodynamics of CLN-619 in Advanced Solid Tumors